Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study

被引:0
|
作者
Gurley, Tami [1 ]
Hernaez, Ruben [2 ,3 ]
Cerda, Vanessa [1 ]
Thomas, Tynaje [1 ]
Narasimman, Manasa [4 ]
Mittal, Sukul [4 ]
Al-Hasan, Mohammed [4 ]
Daher, Darine [4 ]
Singal, Amit G. [4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Donnell Sch Publ Hlth, Dallas, TX USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Houston, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
关键词
Liver cancer; Screening; Ultrasound; Outreach; Interventions; HEPATOCELLULAR-CARCINOMA SURVEILLANCE; DECOMPENSATED CIRRHOSIS; ASSOCIATION; OUTCOMES; QUALITY; DISEASE; LIFE;
D O I
10.1016/j.eclinm.2025.103113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC), but few undergo guideline- recommended semi-annual screening. Randomized clinical trials (RCTs) demonstrate that mailed outreach can increase screening versus visit-based screening. We estimated the costs and cost-effectiveness of an outreach strategy versus usual care. Methods We built a 10-year Markov chain Monte Carlo microsimulation model to conduct a cost-effectiveness analysis comparing a mailed outreach program versus usual care for HCC screening in a cohort of 10,000 patients with cirrhosis. Model inputs were based on literature review (2005-current), and costs were based on inflation-adjusted estimates from Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data. We conducted one-way sensitivity analyses for HCC incidence, outreach costs, efficacy of the outreach strategy to increase screening, and efficacy of curative (versus palliative) HCC treatments. Findings Mailed outreach was estimated to cost $32.45 per patient in the first year and $21.90 per patient in subsequent years. The outreach program increased the number of HCC patients detected at an early stage by 48.4% and increased quality-adjusted life years (QALYs) by 300. Cost savings from these increases offset the costs of mailed outreach. Mailed outreach remained cost-effective across a wide range of HCC incidence rates, outreach costs, efficacy of the outreach strategy to increase screening, and the efficacy of curative HCC treatments. Annual out-ofpocket patient costs in the outreach arm were low at $13 per year. Interpretation Mailed outreach to encourage HCC screening in patients with cirrhosis dominates usual care and should be considered for implementation in routine practice. Funding National Cancer Institute and Cancer Prevention Research Institute of Texas. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of a Colonoscopy Screening Navigator Program Designed for Hispanic Men
    Fernando A. Wilson
    Roberto Villarreal
    Jim P. Stimpson
    José A. Pagán
    Journal of Cancer Education, 2015, 30 : 260 - 267
  • [42] Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
    Aronsson, Mattias
    Svennberg, Emma
    Rosenqvist, Marten
    Engdahl, Johan
    Al-Khalili, Faris
    Friberg, Leif
    Frykman, Viveka
    Levin, Lars-Ake
    EUROPACE, 2017, 19 (10): : 1650 - 1656
  • [43] A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics
    Meenan, Richard T.
    Coronado, Gloria D.
    Petrik, Amanda
    Green, Beverly B.
    PREVENTIVE MEDICINE, 2019, 120 : 119 - 125
  • [44] Cost-Effectiveness Analysis of a Colonoscopy Screening Navigator Program Designed for Hispanic Men
    Wilson, Fernando A.
    Villarreal, Roberto
    Stimpson, Jim P.
    Pagan, Jose A.
    JOURNAL OF CANCER EDUCATION, 2015, 30 (02) : 260 - 267
  • [45] SCREENING FOR SCOLIOSIS - A COST-EFFECTIVENESS ANALYSIS
    MONTGOMERY, F
    PERSSON, U
    BENONI, G
    WILLNER, S
    LINDGREN, B
    SPINE, 1990, 15 (02) : 67 - 70
  • [46] Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
    Lyth, Johan
    Svennberg, Emma
    Bernfort, Lars
    Aronsson, Mattias
    Frykman, Viveka
    Al-Khalili, Faris
    Friberg, Leif
    Rosenqvist, Marten
    Engdahl, Johan
    Levin, Lars-Ake
    EUROPEAN HEART JOURNAL, 2023, 44 (03) : 196 - +
  • [47] Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study
    Bristow, Claire C.
    Larson, Elysia
    Anderson, Laura J.
    Klausner, Jeffrey D.
    SEXUALLY TRANSMITTED INFECTIONS, 2016, 92 (05) : 340 - 346
  • [48] Cost-Effectiveness of Screening Mammography Beyond Age 75 Years A Cost-Effectiveness Analysis
    Schousboe, John T.
    Sprague, Brian L.
    Abraham, Linn
    O'Meara, Ellen S.
    Onega, Tracy
    Advani, Shailesh
    Henderson, Louise M.
    Wernli, Karen J.
    Zhang, Dongyu
    Miglioretti, Diana L.
    Braithwaite, Dejana
    Kerlikowske, Karla
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 11 - +
  • [49] The cost-effectiveness of a program to reduce intrapartum and neonatal mortality in a referral hospital in Ghana
    Bogdewic, Stephanie
    Ramaswamy, Rohit
    Goodman, David M.
    Srofenyoh, Emmanuel K.
    Ucer, Sebnem
    Owen, Medge D.
    PLOS ONE, 2020, 15 (11):
  • [50] Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease
    Okubo, Reiko
    Kondo, Masahide
    Hoshi, Shu-ling
    Yamagata, Kunihiro
    SLEEP AND BREATHING, 2015, 19 (03) : 1081 - 1092